Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 678487, 16 pages
http://dx.doi.org/10.1155/2015/678487
Research Article

Ferulic Acid Induces Th1 Responses by Modulating the Function of Dendritic Cells and Ameliorates Th2-Mediated Allergic Airway Inflammation in Mice

1Department of Microbiology and Immunology, School of Medicine, China Medical University, Taichung 40402, Taiwan
2School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan
3Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
4Department of Microbiology and Immunology, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan

Received 18 June 2015; Accepted 2 September 2015

Academic Editor: Alexandre de Paula Rogerio

Copyright © 2015 Chen-Chen Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Lloyd and S. Saglani, “T cells in asthma: influences of genetics, environment, and T-cell plasticity,” The Journal of Allergy and Clinical Immunology, vol. 131, no. 5, pp. 1267–1275, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. S. J. Galli, M. Tsai, and A. M. Piliponsky, “The development of allergic inflammation,” Nature, vol. 454, no. 7203, pp. 445–454, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Moser and K. M. Murphy, “Dendritic cell regulation of TH1-TH2 development,” Nature Immunology, vol. 1, no. 3, pp. 199–205, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Akbari and D. T. Umetsu, “Role of regulatory dendritic cells in allergy and asthma,” Current Allergy and Asthma Reports, vol. 5, no. 1, pp. 56–61, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Amsen, J. M. Blander, G. R. Lee, K. Tanigaki, T. Honjo, and R. A. Flavell, “Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells,” Cell, vol. 117, no. 4, pp. 515–526, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. M. D'Archivio, C. Filesi, R. Di Benedetto, R. Gargiulo, C. Giovannini, and R. Masella, “Polyphenols, dietary sources and bioavailability,” Annali dell'Istituto Superiore di Sanita, vol. 43, no. 4, pp. 348–361, 2007. View at Google Scholar · View at Scopus
  7. E. Barone, V. Calabrese, and C. Mancuso, “Ferulic acid and its therapeutic potential as a hormetin for age-related diseases,” Biogerontology, vol. 10, no. 2, pp. 97–108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Rondini, M.-N. Peyrat-Maillard, A. Marsset-Baglieri, and C. Berset, “Sulfated ferulic acid is the main in vivo metabolite found after short-term ingestion of free ferulic acid in rats,” Journal of Agricultural and Food Chemistry, vol. 50, no. 10, pp. 3037–3041, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Kim, S. J. Choi, S.-T. Lim et al., “Ferulic acid supplementation prevents trimethyltin-induced cognitive deficits in mice,” Bioscience, Biotechnology and Biochemistry, vol. 71, no. 4, pp. 1063–1068, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Zhu, Q.-H. Liang, X.-G. Xiong et al., “Anti-inflammatory effects of the bioactive compound ferulic acid contained in oldenlandia diffusa on collagen-induced arthritis in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 573801, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Roy, S. K. Metya, S. Sannigrahi, N. Rahaman, and F. Ahmed, “Treatment with ferulic acid to rats with streptozotocin-induced diabetes: effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic beta cell,” Endocrine, vol. 44, no. 2, pp. 369–379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Baskaran, S. Manoharan, S. Balakrishnan, and P. Pugalendhi, “Chemopreventive potential of ferulic acid in 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in Sprague-Dawley rats,” European Journal of Pharmacology, vol. 637, no. 1–3, pp. 22–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K.-J. Liu, S.-J. Leu, C.-H. Su, B.-L. Chiang, Y.-L. Chen, and Y.-L. Lee, “Administration of polysaccharides from Antrodia camphorata modulates dendritic cell function and alleviates allergen-induced T helper type 2 responses in a mouse model of asthma,” Immunology, vol. 129, no. 3, pp. 351–362, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H.-M. Huang, G. Hsiao, C.-K. Fan et al., “Notch ligand delta-like 4-pretreated dendritic cells alleviate allergic airway responses by enhancing IL-10 production,” PLoS ONE, vol. 8, no. 5, Article ID e63613, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Amsen, A. Antov, and R. A. Flavell, “The different faces of Notch in T-helper-cell differentiation,” Nature Reviews Immunology, vol. 9, no. 2, pp. 116–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. S. Yuan, P. C. Kousis, S. Suliman, I. Visan, and C. J. Guidos, “Functions of notch signaling in the immune system: consensus and controversies,” Annual Review of Immunology, vol. 28, pp. 343–365, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Radtke, N. Fasnacht, and H. R. MacDonald, “Notch Signaling in the Immune System,” Immunity, vol. 32, no. 1, pp. 14–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Ito, J. M. Connett, S. L. Kunkel, and A. Matsukawa, “Notch system in the linkage of innate and adaptive immunity,” Journal of Leukocyte Biology, vol. 92, no. 1, pp. 59–65, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Srinivasan, A. R. Sudheer, and V. P. Menon, “Ferulic acid: therapeutic potential through its antioxidant property,” Journal of Clinical Biochemistry and Nutrition, vol. 40, no. 2, pp. 92–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. K. L. Khanduja, P. K. Avti, S. Kumar, N. Mittal, K. K. Sohi, and C. M. Pathak, “Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: a Bcl-2 independent mechanism,” Biochimica et Biophysica Acta, vol. 1760, no. 2, pp. 283–289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Mancuso and R. Santangelo, “Ferulic acid: pharmacological and toxicological aspects,” Food and Chemical Toxicology, vol. 65, pp. 185–195, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Alam, C. Sernia, and L. Brown, “Ferulic acid improves cardiovascular and kidney structure and function in hypertensive rats,” Journal of Cardiovascular Pharmacology, vol. 61, no. 3, pp. 240–249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Y. Kwon, G. M. Do, Y. Y. Cho, Y. B. Park, S. M. Jeon, and M. S. Choi, “Anti-atherogenic property of ferulic acid in apolipoprotein E-deficient mice fed Western diet: comparison with clofibrate,” Food and Chemical Toxicology, vol. 48, no. 8-9, pp. 2298–2303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Hirabayashi, H. Ochiai, S. Sakai, K. Nakajima, and K. Terasawa, “Inhibitory effect of ferulic acid and isoferulic acid on murine interleukin-8 production in response to influenza virus infections in vitro and in vivo,” Planta Medica, vol. 61, no. 3, pp. 221–226, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Sakai, H. Kawamata, T. Kogure et al., “Inhibitory effect of ferulic acid and isoferulic acid on the production of macrophage inflammatory protein-2 in response to respiratory syncytial virus infection in RAW264.7 cells,” Mediators of Inflammation, vol. 8, no. 3, pp. 173–175, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Ou, L.-Y. Kong, X.-M. Zhang, and M. Niwa, “Oxidation of ferulic acid by Momordica charantia peroxidase and related anti-inflammation activity changes,” Biological and Pharmaceutical Bulletin, vol. 26, no. 11, pp. 1511–1516, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Kadowaki, “Dendritic cells: a conductor of T cell differentiation,” Allergology International, vol. 56, no. 3, pp. 193–199, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Kool, H. Hammad, and B. N. Lambrecht, “Cellular networks controlling Th2 polarization in allergy and immunity,” F1000 Biology Reports, vol. 4, article 6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Vroman, B. van den Blink, and M. Kool, “Mode of dendritic cell activation: the decisive hand in Th2/Th17 cell differentiation. Implications in asthma severity?” Immunobiology, vol. 220, no. 2, pp. 254–261, 2015. View at Publisher · View at Google Scholar
  30. A.-K. Yi, J.-G. Yoon, S.-J. Yeo, S.-C. Hong, B. K. English, and A. M. Krieg, “Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response,” Journal of Immunology, vol. 168, no. 9, pp. 4711–4720, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Agrawal, A. Agrawal, B. Doughty et al., “Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos,” The Journal of Immunology, vol. 171, no. 10, pp. 4984–4989, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Khan, S. S. Rahim, C. S. Boddupalli et al., “Hydrogen peroxide inhibits IL-12 p40 induction in macrophages by inhibiting c-rel translocation to the nucleus through activation of calmodulin protein,” Blood, vol. 107, no. 4, pp. 1513–1520, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Sun, C. J. Krawczyk, and E. J. Pearce, “Suppression of Th2 cell development by Notch ligands Delta1 and Delta4,” Journal of Immunology, vol. 180, no. 3, pp. 1655–1661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Tada, K. Tayama, and N. Aoki, “Acute oral toxicity of ferulic acid, natural food additive, in rats,” Annual Report of The Tokyo Metropolitan Research Laboratory of Public Health, vol. 50, pp. 311–313, 1999. View at Google Scholar
  35. Q. Hamid and M. Tulic, “Immunobiology of asthma,” Annual Review of Physiology, vol. 71, pp. 489–507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. F. D. Finkelman, S. P. Hogan, G. K. Khurana Hershey, M. E. Rothenberg, and M. Wills-Karp, “Importance of cytokines in murine allergic airway disease and human asthma,” Journal of Immunology, vol. 184, no. 4, pp. 1663–1674, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Kelly, J. M. Hwang, and P. Kubes, “Modulating leukocyte recruitment in inflammation,” The Journal of Allergy and Clinical Immunology, vol. 120, no. 1, pp. 3–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Gallelli, M. T. Busceti, A. Vatrella, R. Maselli, and G. Pelaia, “Update on anticytokine treatment for asthma,” BioMed Research International, vol. 2013, Article ID 104315, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. N.-I. Kang, H.-Y. Yoon, Y.-R. Lee et al., “A20 attenuates allergic airway inflammation in mice,” The Journal of Immunology, vol. 183, no. 2, pp. 1488–1495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Garcia, C. Taillé, P. Laveneziana, A. Bourdin, P. Chanez, and M. Humbert, “Anti-interleukin-5 therapy in severe asthma,” European Respiratory Review, vol. 22, no. 129, pp. 251–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Gosset, A. Tsicopoulos, B. Wallaert, M. Joseph, A. Capron, and A.-B. Tonnel, “Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation,” The American Review of Respiratory Disease, vol. 146, no. 3, pp. 768–774, 1992. View at Publisher · View at Google Scholar · View at Scopus
  42. C. M. Lilly, H. Nakamura, H. Kesselman et al., “Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids,” The Journal of Clinical Investigation, vol. 99, no. 7, pp. 1767–1773, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. D. A. Kuperman, X. Huang, L. L. Koth et al., “Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma,” Nature Medicine, vol. 8, no. 8, pp. 885–889, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Corren, “Role of interleukin-13 in asthma,” Current Allergy and Asthma Reports, vol. 13, no. 5, pp. 415–420, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. P. L. Vieira, J. R. Christensen, S. Minaee et al., “IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells,” The Journal of Immunology, vol. 172, no. 10, pp. 5986–5993, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. F. J. Barrat, D. J. Cua, A. Boonstra et al., “In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines,” Journal of Experimental Medicine, vol. 195, no. 5, pp. 603–616, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Iwamoto, H. Nakajima, H. Endo, and S. Yoshida, “Interferon γ regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells,” The Journal of Experimental Medicine, vol. 177, no. 2, pp. 573–576, 1993. View at Publisher · View at Google Scholar · View at Scopus
  48. X.-M. Li, R. K. Chopra, T.-Y. Chou, B. H. Schofield, M. Wills-Karp, and S.-K. Huang, “Mucosal IFN-γ gene transfer inhibits pulmonary allergic responses in mice,” Journal of Immunology, vol. 157, no. 8, pp. 3216–3219, 1996. View at Google Scholar · View at Scopus
  49. K. Nakagome, K. Okunishi, M. Imamura et al., “IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine,” Journal of Immunology, vol. 183, no. 1, pp. 209–220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Mitchell, K. Provost, N. Niu, R. Homer, and L. Cohn, “IFN-γ acts on the airway epithelium to inhibit local and systemic pathology in allergic airway disease,” The Journal of Immunology, vol. 187, no. 7, pp. 3815–3820, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. N. G. Papadopoulos, L. A. Stanciu, A. Papi, S. T. Holgate, and S. L. Johnston, “A defective type 1 response to rhinovirus in atopic asthma,” Thorax, vol. 57, no. 4, pp. 328–332, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. G. D. Brooks, K. A. Buchta, C. A. Swenson, J. E. Gern, and W. W. Busse, “Rhinovirus-induced interferon-γ and airway responsiveness in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 9, pp. 1091–1094, 2003. View at Publisher · View at Google Scholar · View at Scopus